🔎 Trials Near Me

Akèy › Maladi Parkinson › North Carolina

Etid klinik pou Maladi Parkinson nan North Carolina

14 etid pou Maladi Parkinson ap chèche patisipan nan sit nan North Carolina.

Vil nan North Carolina

Tèks ofisyèl etid la (Anglè)

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

  • University of North Carolina - Chapel Hill, Chapel Hill
Ap rekriteFaz 2
Laj 40 a 80 · Tout sèks · Mizajou Oct 2, 2026 · NCT06680830

A Study of Buntanetap in Participants With PD

  • Duke Department of Neurosurgery, Durham
Ap rekriteFaz 2/3
Laj 40 a 85 · Tout sèks · Mizajou Sep 21, 2026 · NCT07284784

Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

  • Wake Forest University School of Medicine, Winston-Salem
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT02071134

A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

  • Asheville Neurology Specialists, P.A. (Site #229), Asheville
  • Duke Neurological Disorders Clinic (Site #210), Durham
Ap rekriteFaz 2
Laj 30 a 80 · Tout sèks · Mizajou Sep 10, 2026 · NCT07432958

Parkinson's Foundation PD GENEration Genetic Registry

  • University of North Carolina - Chapel Hill, Chapel Hill
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT04994015

Deep Brain Stimulation (DBS) Retrospective Outcomes Study

  • Wake Forest University School of Medicine, Winston-Salem
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 3, 2026 · NCT03664609

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

  • Asheville Neurology, Asheville
  • Duke University Medical Center, Durham
Ap rekriteFaz 3
Laj 50 a 85 · Tout sèks · Mizajou Sep 3, 2026 · NCT07174310

A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

  • Duke Neurological Disorders Clinic, Durham
Ap rekriteFaz 3
Laj 45 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06944522

Apathy in Parkinson Disease TMS Study

  • UNC-Chapel Hill, Cassidy Lab, Chapel Hill
Ap rekrite
Laj 55 a 80 · Tout sèks · Mizajou Jul 8, 2026 · NCT06087926

Targeted Motor Learning to Improve Gait for Individuals With Parkinson Disease

  • University of North Carolina at Chapel Hill, Chapel Hill
Ap rekrite
Laj 50 a 80 · Tout sèks · Mizajou Jun 25, 2026 · NCT05864157

Use of CereGate Therapy for Freezing of Gait in PD

  • Wake Forest University, Winston-Salem
Ap rekrite
Laj 21 a 80 · Tout sèks · Mizajou May 28, 2026 · NCT05292794

Retinal Imaging in Neurodegenerative Disease

  • Duke University Medical Center, Durham
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Feb 4, 2026 · NCT03233646

A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

  • Atrium Health Wake Forest Baptist Adult Neurology - Janeway Tower, Winston-Salem
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2025 · NCT06765668

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.